2 completed, 2 no longer available. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Hypoplasminogenemia: new trials by email Literature Review of Hypoplasminogenemia trials Research Report on Hypoplasminogenemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Prometic Plasminogen IV Infusion in Subjects With Hypoplasminogenemia Plasminogen (Human) intravenous - Hypoplasminogenemia, Congenital Plasminogen Deficiency | Phase 2 / Phase 3 | Completed | Prometic Biotherapeutics, Inc. | 15 | 2016-05-04 | 2021-08-02 |
| A Phase 1 Study of ProMetic Plasminogen (Human) Intravenous in Adults and Children With Plasminogen Deficiency Plasminogen (Human) Intravenous - Type I Plasminogen Deficiency, Hypoplasminogenemia | Phase 1 | Completed | Prometic Biotherapeutics, Inc. | 7 | 2014-12-01 | 2017-08-29 |
| A Treatment Protocol for Expanded Access Administration of Prometic Plasminogen Due to Closure of Clinical Trial Ryplazim - Hypoplasminogenemia | No longer available | Prometic Biotherapeutics, Inc. | 2022-12-09 | |||
| A Single-patient Study of Repeat-dose Administration of Prometic Plasminogen (Human) Intravenous Plasminogen (Human) - Hypoplasminogenemia | No longer available | Prometic Biotherapeutics, Inc. | 2020-04-24 |
Congenital Plasminogen Deficiency (4) · Plasminogen Deficiency, Type I (1)
Plasminogen (3)
Prometic Biotherapeutics, Inc. (4)
United States (3) · Norway (1)
Amy Shapiro, MD (1) · Heather McDaniel, MD (1) · Jeremy Lorber, MD (1)